Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,124 | 154 | 93.5% |
| Education | $147.22 | 5 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $652.34 | 50 | $0 (2020) |
| AbbVie Inc. | $308.78 | 25 | $0 (2020) |
| PFIZER INC. | $212.90 | 16 | $0 (2020) |
| 180 Medical, Inc. | $201.27 | 12 | $0 (2020) |
| Janssen Biotech, Inc. | $128.28 | 7 | $0 (2021) |
| TOLMAR Pharmaceuticals, Inc. | $102.38 | 5 | $0 (2020) |
| Allergan, Inc. | $69.46 | 6 | $0 (2020) |
| Cogentix Medical Inc. | $55.66 | 3 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $54.49 | 4 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $52.32 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $57.42 | 3 | Janssen Biotech, Inc. ($57.42) |
| 2020 | $239.88 | 14 | Astellas Pharma US Inc ($44.45) |
| 2019 | $488.76 | 31 | TOLMAR Pharmaceuticals, Inc. ($64.15) |
| 2018 | $722.66 | 50 | Astellas Pharma US Inc ($359.47) |
| 2017 | $762.41 | 61 | AbbVie, Inc. ($231.52) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Oncology | ||||||
| 09/23/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Oncology | ||||||
| 08/13/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Oncology | ||||||
| 08/26/2020 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Prostate Cancer | ||||||
| 08/07/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/22/2020 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Prostate Cancer | ||||||
| 07/21/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2020 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/26/2020 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | Cash or cash equivalent | $25.10 | General |
| Category: CONTINENCE AND CRITICAL CARE | ||||||
| 03/12/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: UROLOGY | ||||||
| 03/04/2020 | Coloplast Corp | SPEEDICATH (Device) | Education | Cash or cash equivalent | $15.17 | General |
| Category: CONTINENCE | ||||||
| 02/19/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Interventional Urology | ||||||
| 01/22/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2020 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: CONTINENCE AND CRITICAL CARE | ||||||
| 12/06/2019 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 10/09/2019 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Prostate Cancer | ||||||
| 10/05/2019 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 10/03/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Oncology | ||||||
| 09/10/2019 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Prostate Cancer | ||||||
| 09/04/2019 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: UROLOGY | ||||||
| 09/03/2019 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Interventional Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 14 | 1,118 | 1,432 | $174,817 | $57,532 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 306 | 330 | $36,350 | $14,167 | 39.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 11 | 80 | $52,000 | $14,038 | 27.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 74 | 80 | $32,000 | $10,663 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 108 | 122 | $19,070 | $8,459 | 44.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 75 | $9,000 | $4,282 | 47.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $4,370 | $1,573 | 36.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 358 | 486 | $7,290 | $1,079 | 14.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 21 | 29 | $1,740 | $898.34 | 51.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 88 | 99 | $8,415 | $658.31 | 7.8% |
| 84153 | Psa (prostate specific antigen) measurement | Office | 2020 | 22 | 25 | $1,025 | $456.79 | 44.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 18 | 18 | $1,230 | $381.47 | 31.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 11 | $550.00 | $378.64 | 68.8% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2020 | 11 | 15 | $1,425 | $368.80 | 25.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 38 | 44 | $352.00 | $128.34 | 36.5% |
About Dr. Christopher Kopp, M.D
Dr. Christopher Kopp, M.D is a Urology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679568596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Kopp, M.D has received a total of $2,271 in payments from pharmaceutical and medical device companies, with $57.42 received in 2021. These payments were reported across 159 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,124).
As a Medicare-enrolled provider, Kopp has provided services to 1,118 Medicare beneficiaries, totaling 1,432 services with total Medicare billing of $57,532. Data is available for 1 year (2020–2020), covering 14 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Fort Myers, FL
- Active Since 09/16/2005
- Last Updated 12/03/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1679568596
Products in Payments
- XTANDI (Drug) $348.80
- Androgel (Drug) $264.72
- Myrbetriq (Drug) $191.67
- GENTLECATH (Device) $189.39
- ELIGARD (Drug) $102.38
- MYRBETRIQ (Drug) $93.06
- TOVIAZ (Drug) $65.26
- Erleada (Drug) $59.37
- ERLEADA (Drug) $57.42
- Urgent PC (Device) $55.66
- Xofigo (Drug) $54.49
- VESICARE (Drug) $50.78
- Prolia (Biological) $45.48
- UroLift (Device) $41.87
- FIRMAGON (Drug) $39.65
- KEYTRUDA (Biological) $38.59
- Noctiva (Drug) $35.77
- Cios Alpha (Device) $31.00
- Uribel (Drug) $29.15
- XIAFLEX (Biological) $26.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Fort Myers
Scott Caesar, Md, MD
Urology — Payments: $29,594
Dr. Joseph Klink, M.d, M.D
Urology — Payments: $17,295
Brian Schwartz, Md, MD
Urology — Payments: $16,771
Veronique Fernandez-Salvador, Md, MD
Urology — Payments: $11,820
Alejandro Miranda-Sousa, M.d, M.D
Urology — Payments: $9,173
Dr. John Lee, M.d, M.D
Urology — Payments: $8,446